Novel pregnanoic acid derivatives
    1.
    发明授权
    Novel pregnanoic acid derivatives 失效
    新型孕激素衍生物

    公开(公告)号:US3833563A

    公开(公告)日:1974-09-03

    申请号:US29452772

    申请日:1972-10-03

    申请人: SCHERING AG

    CPC分类号: A61K31/573 C07J5/00

    摘要: CH=),8-X-PERHYDROBENZ(E)INDENE

    PREGNANOIC ACID DERIVATIVES OF THE FORMULA

    2-R1,3-(R3O-CO-CH(-OR2)-),3A,6-DI(H3C-),5-Z,6,7-(-B-A-CO-
    WHEREIN THE GROUP OR2 IS IN THE AF- OR BF-POSITION; X IS HYDROGEN, HALOGEN OR METHYL; Y IS HYDROGEN OR HALOGEN; Z IS HYDROXY OR HALOGEN HAVING AN ATOMIC WEIGHT NO GREATER THAN Y; R1 IS HYDROGEN OR METHYL; R2 IS HYDROGEN OR ACYL AND R3 IS HYDROGEN, ALKALI METAL OR SATURATED OR UNSATURATED UNSUBSTITUTED OR SUBSTITUTED HYDROCARBON OF 1-18 CARBON ATOMS, OR COLLECTIVELY R2 AND R3 ARE DIALKYLMETHYLENE OR CYCLOALKYLIDENE; AND AT LEAST ONE OF X, Y AND R1 ARE OTHER THAN HYDROGEN; AND -A-B- IS

    -CH2-CH2-, -CH=CH- OR -CCL=CH;

    POSSESS PRONOUNCED TOPICAL ANTI-INFLAMMATORY ACTIVITY AS WELL AS BEING INTERMEDIATES FOR THE PRODUCTION OF THE CORRESPONDING 20-KETO STEROIDS.

    Process for the preparation of 6-keto-delta1,3,5(10)steroids
    2.
    发明授权
    Process for the preparation of 6-keto-delta1,3,5(10)steroids 失效
    制备6-KETO-DELTA 1,3,5(10)STEROIDS的方法

    公开(公告)号:US3813418A

    公开(公告)日:1974-05-28

    申请号:US27107672

    申请日:1972-07-12

    申请人: SCHERING AG

    摘要: A-RING AROMATIC STEROIDS HAVING ESTROGENIC ACTIVITY OF THE GENERAL FORMULA

    3-(R7-O-),13-R1,17-(R2=)GONA-1,3,5(10)-TRIEN-6-ONE

    WHEREIN R1 IS ALKYL OF 1-3 CARBON ATOMS; R2 IS =O,

    (R3-O-),(R4-)

    IN WHICH R3 IS HYDROGEN OR ACYL OF UP TO 6 CARBON ATOMS AND R4 IS HYDROGEN OR SATURATED OR UNSATURATED ALKYL OF UP TO 4 CARBON ATOMS, OR

    (R5-CH2-CO-),(R6-)

    IN WHICH R5 AND R6 ARE HYDROGEN, HYDROXY OR ACYLOXY, AND R7 IS HYDROGEN, ALKYL OF UP TO 4 CARBON ATOMS OR ACYL, ARE PREPARED BY REACTING A 3-KETONE-$4-STEROID OF THE GENERAL FORMULA

    13-R1,17-(R2=)GON-4-EN-3-ONE

    WHEREIN R1 AND R2 HAVE THE VALUES GIVEN ABOVE, WITH A BASIC REAGENT IN A HIGH-BOILING POLAR SOLVENT IN THE PRESENCE OF OXYGEN AT TEMPERATURES OF 70-150* C.; AND OPTIONALLY THEREAFTER ESTERIFYING OR ETHERIFYING ANY FREE HYDROXY GROUPS PRESENT IN THE PRODUCT IN A CONVENTIONAL MANNER.

    Process for the preparation of 16,17-unsaturated steroids
    3.
    发明授权
    Process for the preparation of 16,17-unsaturated steroids 失效
    制备16,17-不饱和脂肪族甾体的方法

    公开(公告)号:US3842105A

    公开(公告)日:1974-10-15

    申请号:US33106073

    申请日:1973-02-09

    申请人: SCHERING AG

    CPC分类号: C07J5/00

    摘要: R1,R3 AND Y HAVE THE SAME ABOVE-INDICATED MEANINGS AND R2. STANDS FOR HYDROGEN OR LOWER ALKYL IN A POLAR ORGANIC SOLVENT, IN THE PRESENCE OF AN ALKALI OR ALKALINE EARTH SALT OF A LOWER ALKANOIC ACID OF 1-5 CARBON ATOMS, OF A CARBONIC ACID, OF OF AN AROMATIC CARBOXYLIC ACID TO FORM SAID 21-ACYLOXY-STEROID.

    C1--C2, C5---C7,

    IS A DOUBLE BOND, R2 IS H OR LOWER ALKYL, R3 IS LOWER ALKANOYL IS OF 1-5 CARBON ATOMS AND Y IS HYDROGEN OR FLUORINE, WHICH COMPRISES HEATING AT A TEMPERATURE FROM ABOUT 80*C. TO THE BOILING POINT OF THE REACTION SOLVENT A NON-ESTERIFIED 11B, 17, 21 - TRIHYDROXY-2-KETO-PREGNANE OF THE FORMULA 3,21-DI(O=),6-R1,9-Y,11-(HO-),16-R2,20-(R3-O-)PREGNA-1,4,6,16-TETRAENE PREGNA-1,4,6,17(20)-TETRAENE WHEREIN

    C6-----7

    IS A SINGLE BOND, OR FLUORINE, CHLORINE, BROMINE OR METHYL WHEN

    C6-----7

    EACH REPRESENT A SATURATED OR UNSATURATED CARBON-TO-CARBON BOND, R1 IS H OR METHYL IN THE A- OR B-POSITION WHEN

    C1-------C2 AND C6 -------C7

    1. A PROCESS FOR THE PRODUCTION OF $4.16-11B-HYDROXY3,20-DIKETO-21-ACYLOXY STEROIDS OF THE FORMULA 3,20-DI(O=),6-R1,9-Y,11-(HO-),16-R2,21-(R3-O-)-18-NORWHEREIN

    Novel pregnanoic acid derivatives

    公开(公告)号:US3824260A

    公开(公告)日:1974-07-16

    申请号:US28471072

    申请日:1972-08-30

    申请人: SCHERING AG

    IPC分类号: C07D20060101 C07C169/36

    摘要: PREGNANOIC ACID DERIVATIVES OF THE FORMULA

    2-R1,3-(R2O-CO-CO-),3A-(H3C-),5-Z,5A-Y,6-(H3C-),6,7-(-A-B-

    CO-CH=),8-X-PERHYDRO-BENZ(E)INDENE

    WHEREIN X IS HYDROGEN,HALOGEN,ORMETHYL; Y IS HYDROGEN ORHALOGEN; Z IS HYDROXY OR HALOGEN HAVING AN ATOMIC WEIGHT NO GREATER THAN Y; R1 IS HYDROGEN OR METHYL; R2 IS HYDROGEN, ALKALI METAL OR SUBSTITUTED OR UNSUBSTITUTED HYDROCARBON OF 1-8 CARBON ATOMS WHICH IS UNSUBSTITUTED OR SUBSTITUTED BY HYDROXY, HALO, ALKOXY, CARBOXY, CARBALKOXY, AMINO, ALKYLAMINO, DIALKYLAMINO, NITRO OR SULFATO, WHEREIN ALKYL IN EACH INSTANCE CONTAINS 1-4 CARBON ATOMS; AND --A--B--IS--CH=CH--,--CCI=CH-- OR, WHEN AT LEAST ONE OF X, Y AND R1 IS OTHER THAN HYDROGEN, --CH2--CH2; PROCESS PRONOUNCED TOPICAL ANTI-INFLAMMATORY ACTIVITY.